使用美国癌症分期标准联合委员会和国家综合癌症网络指南评估“高风险”皮肤鳞状细胞癌的定义。

IF 1.2 Q3 DERMATOLOGY
Journal of Skin Cancer Pub Date : 2014-01-01 Epub Date: 2014-09-17 DOI:10.1155/2014/154340
Melinda B Chu, Jordan B Slutsky, Maulik M Dhandha, Brandon T Beal, Eric S Armbrecht, Ronald J Walker, Mark A Varvares, Scott W Fosko
{"title":"使用美国癌症分期标准联合委员会和国家综合癌症网络指南评估“高风险”皮肤鳞状细胞癌的定义。","authors":"Melinda B Chu,&nbsp;Jordan B Slutsky,&nbsp;Maulik M Dhandha,&nbsp;Brandon T Beal,&nbsp;Eric S Armbrecht,&nbsp;Ronald J Walker,&nbsp;Mark A Varvares,&nbsp;Scott W Fosko","doi":"10.1155/2014/154340","DOIUrl":null,"url":null,"abstract":"<p><p>Recent guidelines from the American Joint Committee on Cancer (AJCC) and National Comprehensive Cancer Network (NCCN) have been proposed for the assessment of \"high-risk\" cutaneous squamous cell carcinomas (cSCCs). Though different in perspective, both guidelines share the common goals of trying to identify \"high-risk\" cSCCs and improving patient outcomes. Thus, in theory, both definitions should identify a similar proportion of \"high-risk\" tumors. We sought to evaluate the AJCC and NCCN definitions of \"high-risk\" cSCCs and to assess their concordance. Methods. A retrospective review of head and neck cSCCs seen by an academic dermatology department from July 2010 to November 2011 was performed. Results. By AJCC criteria, most tumors (n = 211,82.1%) were of Stage 1; 46 tumors (13.9%) were of Stage 2. Almost all were of Stage 2 due to size alone (≥2 cm); one tumor was \"upstaged\" due to \"high-risk features.\" Using the NCCN taxonomy, 231 (87%) of tumors were \"high-risk.\" Discussion. This analysis demonstrates discordance between AJCC and NCCN definitions of \"high-risk\" cSCC. Few cSCCs are of Stage 2 by AJCC criteria, while most are \"high-risk\" by the NCCN guidelines. While the current guidelines represent significant progress, further studies are needed to generate a unified definition of \"high-risk\" cSCC to optimize management. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"154340"},"PeriodicalIF":1.2000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/154340","citationCount":"40","resultStr":"{\"title\":\"Evaluation of the definitions of \\\"high-risk\\\" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.\",\"authors\":\"Melinda B Chu,&nbsp;Jordan B Slutsky,&nbsp;Maulik M Dhandha,&nbsp;Brandon T Beal,&nbsp;Eric S Armbrecht,&nbsp;Ronald J Walker,&nbsp;Mark A Varvares,&nbsp;Scott W Fosko\",\"doi\":\"10.1155/2014/154340\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recent guidelines from the American Joint Committee on Cancer (AJCC) and National Comprehensive Cancer Network (NCCN) have been proposed for the assessment of \\\"high-risk\\\" cutaneous squamous cell carcinomas (cSCCs). Though different in perspective, both guidelines share the common goals of trying to identify \\\"high-risk\\\" cSCCs and improving patient outcomes. Thus, in theory, both definitions should identify a similar proportion of \\\"high-risk\\\" tumors. We sought to evaluate the AJCC and NCCN definitions of \\\"high-risk\\\" cSCCs and to assess their concordance. Methods. A retrospective review of head and neck cSCCs seen by an academic dermatology department from July 2010 to November 2011 was performed. Results. By AJCC criteria, most tumors (n = 211,82.1%) were of Stage 1; 46 tumors (13.9%) were of Stage 2. Almost all were of Stage 2 due to size alone (≥2 cm); one tumor was \\\"upstaged\\\" due to \\\"high-risk features.\\\" Using the NCCN taxonomy, 231 (87%) of tumors were \\\"high-risk.\\\" Discussion. This analysis demonstrates discordance between AJCC and NCCN definitions of \\\"high-risk\\\" cSCC. Few cSCCs are of Stage 2 by AJCC criteria, while most are \\\"high-risk\\\" by the NCCN guidelines. While the current guidelines represent significant progress, further studies are needed to generate a unified definition of \\\"high-risk\\\" cSCC to optimize management. </p>\",\"PeriodicalId\":17172,\"journal\":{\"name\":\"Journal of Skin Cancer\",\"volume\":\"2014 \",\"pages\":\"154340\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2014/154340\",\"citationCount\":\"40\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2014/154340\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/9/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/154340","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/9/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 40

摘要

最近,美国癌症联合委员会(AJCC)和国家综合癌症网络(NCCN)提出了评估“高风险”皮肤鳞状细胞癌(cSCCs)的指南。尽管观点不同,但两份指南的共同目标是试图识别“高风险”cSCCs并改善患者预后。因此,理论上,这两种定义应该能识别出相似比例的“高危”肿瘤。我们试图评估AJCC和NCCN对“高风险”cSCCs的定义,并评估其一致性。方法。回顾性分析2010年7月至2011年11月某学术皮肤科收治的头颈部cSCCs病例。结果。根据AJCC标准,大多数肿瘤(n = 211,82.1%)为1期;2期46例(13.9%)。几乎所有患者仅因大小(≥2 cm)而进入第二阶段;一个肿瘤由于“高风险特征”而被“抢了风头”。使用NCCN分类,231例(87%)肿瘤为“高风险”。讨论。这一分析表明AJCC和NCCN对“高风险”cSCC的定义不一致。根据AJCC的标准,很少有cSCCs属于第二阶段,而根据NCCN的指南,大多数cSCCs属于“高风险”。虽然目前的指南取得了重大进展,但需要进一步的研究来形成“高风险”cSCC的统一定义,以优化管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.

Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.

Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.

Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.

Recent guidelines from the American Joint Committee on Cancer (AJCC) and National Comprehensive Cancer Network (NCCN) have been proposed for the assessment of "high-risk" cutaneous squamous cell carcinomas (cSCCs). Though different in perspective, both guidelines share the common goals of trying to identify "high-risk" cSCCs and improving patient outcomes. Thus, in theory, both definitions should identify a similar proportion of "high-risk" tumors. We sought to evaluate the AJCC and NCCN definitions of "high-risk" cSCCs and to assess their concordance. Methods. A retrospective review of head and neck cSCCs seen by an academic dermatology department from July 2010 to November 2011 was performed. Results. By AJCC criteria, most tumors (n = 211,82.1%) were of Stage 1; 46 tumors (13.9%) were of Stage 2. Almost all were of Stage 2 due to size alone (≥2 cm); one tumor was "upstaged" due to "high-risk features." Using the NCCN taxonomy, 231 (87%) of tumors were "high-risk." Discussion. This analysis demonstrates discordance between AJCC and NCCN definitions of "high-risk" cSCC. Few cSCCs are of Stage 2 by AJCC criteria, while most are "high-risk" by the NCCN guidelines. While the current guidelines represent significant progress, further studies are needed to generate a unified definition of "high-risk" cSCC to optimize management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Skin Cancer
Journal of Skin Cancer DERMATOLOGY-
CiteScore
2.30
自引率
18.20%
发文量
12
审稿时长
21 weeks
期刊介绍: Journal of Skin Cancer is a peer-reviewed, Open Access journal that publishes clinical and translational research on the detection, diagnosis, prevention, and treatment of skin malignancies. The journal encourages the submission of original research articles, review articles, and clinical studies related to pathology, prognostic indicators and biomarkers, novel therapies, as well as drug sensitivity and resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信